Average selling prices of Illuccix will likely decrease when its transitional pass-through payment status expires in 2025.

The global topical drug delivery market size was US$ 186.5 billion in 2021. The global topical drug delivery market size is forecast to reach US$ 385.4 billion by 2030, growing at a compound annual ...

The global cancer gene therapy market size was US$ 1.5 billion in 2021. The global cancer gene therapy market is expected to grow to US$ 3.1 billion by 2030 by registering a compound annual growth ...

Trump on Thursday signed an executive order that set new tariffs on a wide swath of U.S. trading partners to go into effect ...

UCB emerged as a major biopharmaceutical player in the 1990s with the development of blockbuster drugs Zyrtec and Keppra. Throughout the 1990s and early 2000s, UCB transformed from a hybrid ...

U.S. trade partners reacted Friday to President Donald Trump’s executive order now set to introduce new tariffs on many of them starting Aug. 7 — as the global economy faces another test from the pres ...

The majority of liver cancer cases could be prevented by reducing levels of viral hepatitis, alcohol consumption and MASLD (metabolic dysfunction-associated steatotic liver disease – previously called ...

Post-operative nausea and vomiting (PONV) market to rise from $2.11B in 2024 to $2.97B in 2029, driven by innovations in ...

The global injectable drug delivery market is experiencing a significant transformation, poised to reach a staggering USD 113 ...

BOSTON and SAN DIEGO, July 23, 2025 (GLOBE NEWSWIRE) -- Ikena Oncology, Inc. (Nasdaq: IKNA) (“Ikena”) and Inmagene Biopharmaceuticals (“Inmagene”) today announced the appointment of Kristin Yarema, Ph ...

The melanoma market is predicted to surge during the forecast period (2025–2034) owing to factors, as the increasing incidence of melanoma, the launc ...